Back to search

United States· US:22840-5319_36ac4a35-6d7b-a249-e063-6294a90a0b70

Rough Redroot Rough Redroot

A medicinal product containing amaranthus retroflexus pollen, registered in United States by Greer Laboratories, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedRough Redroot Rough RedrootATC—REGISTER NO.US:22840-5319_36ac4a3…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
AMARANTHUS RETROFLEXUS POLLEN
Manufacturer
Greer Laboratories, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    2284053192
    10 mL in 1 VIAL, MULTI-DOSE (22840-5319-2)
  • ndc11
    2284053194
    50 mL in 1 VIAL, MULTI-DOSE (22840-5319-4)
  • ndc11
    2284053195
    5 mL in 1 BOTTLE, DROPPER (22840-5319-5)
  • ndc11
    22840-5319-2
  • ndc11
    22840-5319-4
  • ndc11
    22840-5319-5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Amaranthus retroflexus pollen in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amaranthus retroflexus pollen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bebd52f6-b014-44f9-b08d-0aeae17da372
GET /v1/drugs/bebd52f6-b014-44f9-b08d-0aeae17da372?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS",
  "source": "ndc",
  "strength": ".05",
  "substance": "AMARANTHUS RETROFLEXUS POLLEN",
  "productndc": "22840-5319",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/mL",
  "application_number": "BLA101833",
  "marketing_category": "BLA"
}

See everything about amaranthus retroflexus pollen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.